{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:25:58Z","timestamp":1793467558950,"version":"4.5.0"},"reference-count":37,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2018,9,2]]},"DOI":"10.1080\/17474086.2018.1500456","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T04:44:21Z","timestamp":1531457061000},"page":"707-714","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Pacritinib to treat myelofibrosis patients with thrombocytopenia"],"prefix":"10.1080","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2584-6953","authenticated-orcid":false,"given":"Douglas","family":"Tremblay","sequence":"first","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mascarenhas","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,7,19]]},"reference":[{"key":"CIT0001","volume":"346","author":"Hoffman R","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1898"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.2446"},{"issue":"15","key":"CIT0004","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1200\/JCO.2016.34.15_suppl.7068","volume":"34","author":"Alhuraiji A","year":"2016","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"CIT0005","first-page":"200","volume":"130","author":"Vannucchi AM","year":"2017","journal-title":"Blood"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.169"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2864"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110557"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110556"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.2147\/JEP.S110702"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30027-3"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.5818"},{"issue":"71","key":"CIT0013","volume":"451","author":"O\u2019Sullivan JM","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051113"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-554634"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311347"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.130"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030270"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23505"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-482232"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.05.006"},{"issue":"22","key":"CIT0022","first-page":"3905","volume":"114","author":"Verstovsek S","year":"2009","journal-title":"ASH Annual Meeting"},{"key":"CIT0023","doi-asserted-by":"crossref","unstructured":"Al-Fayoumi S, Wang L, Dean JP, et al. Characterization of the pharmacokinetic and pharmacodynamic properties of pacritinib, a novel oral JAK2\/FLT3 inhibitor, in patients with myelofibrosis, AML and lymphoma. Stockholm, Sweden: European Hematology Association; 2013. Abstract P983.","DOI":"10.1182\/blood.V122.21.4080.4080"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1021\/jm200326p"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.148"},{"issue":"2","key":"CIT0026","first-page":"1144","volume":"95","author":"Seymour JF","year":"2010","journal-title":"Haematologica"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-016-0367-x"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.5223"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.29.15_suppl.6515"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-484832"},{"key":"CIT0031","first-page":"278","volume-title":"EHA Annual Conference","author":"Verstovsek S","year":"2013"},{"issue":"21","key":"CIT0032","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood.V122.21.395.395","volume":"122","author":"Dean JP","year":"2013","journal-title":"Blood"},{"key":"CIT0033","volume-title":"CTI biopharma provides update on investigational agent pacritinib","author":"Corp. CB","year":"2016"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3309-6"},{"key":"CIT0035","volume-title":"CTI biopharma announces removal of full clinical hold on pacritinib","author":"Corp CB","year":"2017"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2017.1264268"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0797-y"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2018.1500456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T18:15:06Z","timestamp":1599416106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2018.1500456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,19]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9,2]]}},"alternative-id":["10.1080\/17474086.2018.1500456"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2018.1500456","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-05-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}